Owned and operated by CSIRO on behalf of the nation, the Australian Animal Health Laboratory (AAHL) is Australia's national biocontainment facility. The purpose-built facility enables the highest levels of biocontainment research, helping to protect Australia's livestock and aquatic industries, as well as people, from emerging infectious disease threats.

The second round of the AAHL Science Merit Access Program has opened.

Statement of Purpose

The Merit Access Program invites Australian research organisations wishing to access AAHL's capabilities, to conduct high impact research of national importance on animal and zoonotic diseases that require high levels of biocontainment.

Benefits

Through the program, AAHL will provide in-kind support to successful projects in the form of research collaboration with AAHL Facility staff and laboratory access, as well as a small budget for project consumables (up to $20k). All submissions will be subject to the availability of staff and resources, in addition to facility regulatory requirements.

Research proposals must be capable of being completed by 30 June 2020, however this round is also inviting open EOIs potentially suitable for future rounds of the AAHL Science Merit Program.

Eligibility and conditions

The program guidelines and application form can be found here (PDF, 197KB)

The program application form can be found here (Word, 49KB)

Applications close Thursday 31st October 2019.

Please direct any enquiries or submissions via access2aahl@csiro.au.

Event Date
Issue of EOI 25th September 2019
EOI closing date 31st October 2019
Notification of successful applicants AAHL will notify all applicants about the outcome of their application.

Event date: 31Oct 2019

Thursday 31 Oct 2019

  • Applications close

More information

More about the CSIRO AAHL National Facility

The AAHL national facility has extensive laboratories, including animal facilities, able to host research on pathogens in risk groups 3 and 4. This means that AAHL is able to facilitate complex research of high consequence zoonotic pathogens to support the objectives of Australia’s research community and industry. Examples of research performed by CSIRO and visiting scientists includes diagnostic assay development, the identification and characterisation of new and emerging viruses, comparative immunology, vector studies, preclinical studies of new vaccines and therapeutics, genome engineering for biosecurity purposes and pathogenesis studies. For more information about AAHL visit https://aahl.csiro.au/

AAHL is recognised nationally and internationally as a centre of excellence in disease diagnosis, research, and policy advice in animal health and human diseases of animal origin.

Science areas:

Event type: